Vanberra Signal

Healthy Interactions

Curated by Signal

Patient education and engagement tools

Overview

Healthy Interactions provides patient engagement programs for diabetes and other chronic conditions with Conversation Map group visit tools and a digital coaching platform. Products include Conversation Map tools - health education tools to be used in small group settings where facilitator leads participants through a discussion about a health theme; Conversation Starter tools - education tools for one on one conversations between a facilitator and just one participant; Ancillary tools - complementary tools that provide review of major learning points of the session and allow participants to identify and track goals; and Digital tools such as e-learning modules, Map sessions, and Diabetes App and education tools for iPad. The Conversation MApp is the mobile app for patient engagement and education.

Key facts

Founded
2003

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of practice management software for dental clinics

    Health TechnologyOverland Park, United States
  • Online retailer of generic medicines for erectile dysfunction

    Health TechnologyUnited States
  • Digital payment management tool for hospitals

    Health TechnologyNew York City, United States

About Healthy Interactions

What does Healthy Interactions do?

Healthy Interactions provides patient engagement programs for diabetes and other chronic conditions with Conversation Map group visit tools and a digital coaching platform.

Where is Healthy Interactions headquartered?

Healthy Interactions is headquartered in Chicago, United States.

When was Healthy Interactions founded?

Healthy Interactions was founded in 2003.

Which sector is Healthy Interactions in?

Healthy Interactions operates in Health Technology.

Who are Healthy Interactions's competitors?

Companies similar to Healthy Interactions include A Place for Everything, Drioo.com, and MedReview.